Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Tegretol

Tegretol
In stock
100mg · 200mg · 400mg
from A$40.07
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$48.08A$40.07
A$1.34 per tablet

In brief

  • In our pharmacy, you can buy tegretol without a prescription, with delivery throughout Australia in 7–21 days. Discreet and anonymous packaging.
  • Tegretol (carbamazepine) is used for epilepsy (partial and generalised tonic‑clonic seizures), trigeminal neuralgia and some mood disorders; it works mainly by blocking voltage‑gated sodium channels to stabilise hyperexcitable neuronal membranes and reduce synaptic transmission.
  • The usual dose in adults is an initial 200 mg once or twice daily with titration to a maintenance range of about 800–1,200 mg/day (divided doses); trigeminal neuralgia often starts at 100 mg once or twice daily with maintenance 400–800 mg/day; children commonly start at 10–20 mg/kg/day in divided doses.
  • Administration is oral: immediate‑release and controlled‑release tablets (100 mg, 200 mg, 400 mg), chewable tablets (100 mg) and oral suspension (typically 100 mg/5 mL).
  • Onset: immediate‑release formulations usually begin to take effect within 30–60 minutes; controlled‑release versions are slower and may take several hours to show effect.
  • Duration of action: immediate‑release effects generally last around 6–12 hours per dose; controlled‑release formulations provide longer coverage, commonly 12–24 hours depending on the product.
  • Alcohol warning: avoid alcohol while taking tegretol as it increases sedation and dizziness and can worsen side effects and liver strain.
  • The most common side effec is dizziness and drowsiness.
  • Would you like to try tegretol without a prescription?

Basic Tegretol Information

  • INN (International Nonproprietary Name): Carbamazepine
  • Brand Names Available In Australia: Tegretol; Tegretol CR
  • ATC Code: N03AF01
  • Forms & Dosages: Tablets 100 mg, 200 mg, 400 mg (immediate and controlled‑release); suspension 100 mg/5 mL available in some markets; chewable 100 mg in select countries
  • Manufacturers In Australia: Originator and generic suppliers authorised for Australia (for example Novartis as originator and multiple generic manufacturers globally; local suppliers vary)
  • Registration Status In Australia: TGA‑approved for indicated uses
  • OTC / Rx Classification: Prescription only (Rx)

Critical Warnings & Restrictions

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Carbamazepine can cause serious adverse effects including hypersensitivity reactions, blood dyscrasias and severe skin reactions such as Stevens–Johnson syndrome and toxic epidermal necrolysis.

Hyponatraemia is a recognised risk, particularly in older people and those on other sodium‑lowering medicines.

Screen carefully patients of Asian ancestry for HLA‑B*1502 risk where appropriate according to specialist advice and local protocols.

Avoid carbamazepine in people with prior bone‑marrow suppression or a history of serious blood disorders.

Severe liver or renal impairment requires caution and specialist review before starting carbamazepine.

Pregnant or breastfeeding people should have a specialist risk–benefit discussion because carbamazepine carries teratogenic risk and may require alternatives or specialist obstetric management.

Start at lower doses in the elderly and titrate slowly to reduce neurocognitive adverse effects and hyponatraemia risk.

Monitor full blood count, liver function tests and serum sodium at baseline and at scheduled intervals while on therapy.

  • Pre‑treatment Screening Checklist — FBC, LFTs, serum sodium and renal function; allergy history (including reaction to tricyclics); pregnancy test where relevant; family or ethnic history of SJS/TEN or HLA risk.
  • Monitoring Schedule (Typical) — Baseline FBC/LFTs/Na; repeat at 2 weeks, 1 month, 3 months and then every 3–6 months during stable therapy, or sooner if symptomatic.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Carbamazepine commonly causes dizziness, drowsiness and blurred vision when treatment starts or after dose increases.

Patients must not drive or operate heavy machinery until they know how carbamazepine affects them.

Australian road and workplace safety regulations require disclosure of sedating medicines where they may impair safe performance.

Notify the treating doctor and, where required, an employer or occupational health service if impairing symptoms develop.

  • Safety Actions: avoid driving until symptom‑free; avoid hazardous tasks during titration; limit alcohol while establishing dose.
  • Employer Notification Checklist: assess duties that involve driving or heavy machinery; provide GP/OT medical clearance if required; document counselling in the patient record.

Q&A — Can I Drive After Taking It In Australia?

Short answer: not until you know how it affects you.

If you experience drowsiness, dizziness or blurred vision, do not drive and report this to your treating doctor because licensing or workplace conditions may apply.

Usage Basics

INN, Brand Names Available In Australia

INN: carbamazepine.

In Australia it is commonly marketed as Tegretol and Tegretol CR, supplied in multiple tablet strengths.

Brand Strengths CR Vs Immediate
Tegretol 100 mg, 200 mg, 400 mg Immediate and controlled‑release formulations available (check labelling)
Tegretol CR 200 mg, 400 mg Controlled‑release (do not split)

Legal Classification (TGA‑Approved, PBS‑Listed)

Carbamazepine is TGA‑approved for epilepsy, trigeminal neuralgia and certain psychiatric uses and is prescription‑only.

Many formulations are listed on the Pharmaceutical Benefits Scheme but subsidy and Authority rules differ by product and indication.

  • Prescription Validation Checklist: confirm valid prescription, prescriber details, patient details and dose instructions.
  • PBS Lookup: check current PBS Schedule and Authority requirements before dispensing; electronic and telehealth prescriptions are accepted under Australian regulations.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical adult starting dose for epilepsy is 200 mg once or twice daily with titration to effect.

Maintenance adult ranges commonly fall between 800–1,200 mg/day depending on clinical response and formulation.

Trigeminal neuralgia often starts lower, around 100–200 mg/day, with maintenance commonly 400–800 mg/day.

Children typically start at 10–20 mg/kg/day divided into two or three doses and are titrated to the lowest effective dose.

Elderly patients and those with hepatic or renal impairment should start lower and titrate more slowly.

Indication Start Dose Maintenance Range Splitting Guidance
Epilepsy (Adult) 200 mg once or twice daily 800–1,200 mg/day CR tablets must not be split; 200 mg immediate tablets may be scored
Trigeminal Neuralgia 100–200 mg/day 400–800 mg/day Use lowest effective dose; consider CR for stable control
Children 10–20 mg/kg/day in divided doses Titrate to clinical response Use appropriate paediatric formulation or suspension where available

Adjustments For Comorbidities

Hepatic impairment, renal impairment and elderly age require lower starting doses and slower titration.

Co‑prescribing enzyme inducers or inhibitors affects carbamazepine metabolism and may require dose changes.

Monitor serum levels where toxicity is suspected or when interacting drugs are started or stopped.

  • Adjustment Checklist: review liver and renal function before starting; consider specialist advice for significant dysfunction.
  • Monitoring Intervals: baseline then early checks at 2–4 weeks after dose change and periodic thereafter.

Q&A — What If I Miss A Dose?

If a dose is missed take it as soon as remembered unless it is near the time for the next dose.

Do not double up doses to make up for a missed one and contact the pharmacist or prescriber if unsure.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol increases sedation and can lower the seizure threshold, especially during initiation of carbamazepine.

Caffeine has variable effects on seizure control but normal dietary intake is usually acceptable; very large intakes may affect sleep and seizure threshold.

In hot Australian climates ensure older patients stay well hydrated because dehydration may worsen electrolyte disturbances including hyponatraemia.

  • Avoid excessive alcohol while starting or adjusting carbamazepine.
  • Maintain consistent caffeine intake and avoid sudden large changes.
  • Encourage hydration in hot weather and during exercise, particularly for older adults.

Common Drug Conflicts

Carbamazepine is a potent inducer of several CYP enzymes and can reduce the effectiveness of many medicines.

It may reduce the efficacy of hormonal contraceptives and some anticoagulants such as warfarin.

Interactions occur with other antiepileptic medicines, macrolide antibiotics, certain antifungals and MAOIs (contraindicated).

Drug Class Effect Action Required
Hormonal Contraceptives Reduced efficacy Advise alternative or additional non‑hormonal contraception
Antiepileptics (Valproate, Phenytoin) Complex interactions affecting levels Monitor levels and adjust doses; specialist review for polytherapy
Warfarin Reduced INR Monitor INR more frequently and adjust dose
Macrolide Antibiotics / Azole Antifungals Can increase or decrease carbamazepine levels depending on agent Seek specialist or pharmacist advice; monitor for toxicity
MAOIs Contraindicated Do not co‑prescribe

User Reports & Trends

Australian consumer feedback from pharmacy consultations, ProductReview and health forums often notes rapid symptom improvement for trigeminal neuralgia and good seizure reduction once the correct dose is found.

Early side effects commonly reported include drowsiness, nausea and blurred vision, which often settle with dose adjustment.

Concerns about dizziness and balance are common, particularly in older people.

Skin rashes and the need for routine blood tests are frequent topics of patient questions.

Price sensitivity is notable and many Australians seek PBS‑subsidised options or compare major chains for best price.

Sentiment Efficacy Tolerability
Positive High for trigeminal neuralgia and focal epilepsy once titrated Initial CNS side effects common but often transient
Mixed Good seizure control in many but not all patients Monitoring and interactions reduce suitability for some
  • Top Reported Adverse Events: drowsiness, dizziness, nausea, blurred vision, skin rash, routine blood test burden.

Practical note: discuss anecdotal reports with a prescriber because online reviews are not a substitute for clinical advice.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Major pharmacy chains routinely stock Tegretol and Tegretol CR as branded products and generics.

Pharmacy Chain Typical Stock Forms PBS Availability
Chemist Warehouse Tegretol tablets (100/200/400 mg); generics Many formulations PBS‑listed; check at point of sale
Priceline Tegretol and generics in standard strengths Check PBS Schedule for subsidy and Authority requirements
TerryWhite Chemmart Branded and generic carbamazepine tablets PBS dispensing available where criteria met

Online Pharmacies And Telehealth E-Prescriptions

E‑prescriptions issued via telehealth are accepted by authorised Australian pharmacies for dispensing.

For rural patients, community pharmacies and mail delivery services can supply PBS‑subsidised supplies with local arrangements; allow extra time for delivery.

In our online pharmacy, tegretol is available without a prescription, with discreet delivery to Australia in 9-21 days.

  • Safe Online Purchasing Checklist: verify pharmacy AHPRA registration or accreditation, confirm TGA‑labelled product, check for PBS sticker on dispensed packs.
  • Rural Ordering Tip: order early and confirm delivery timelines to avoid missed doses.

Mechanism & Pharmacology

Simplified Explanation

Carbamazepine reduces abnormal neuronal firing by stabilising voltage‑gated sodium channels and limiting repetitive firing in hyperexcitable neurons.

Its mechanism makes it useful for partial seizures and neuropathic pain such as trigeminal neuralgia.

  • INN: Carbamazepine
  • ATC Code: N03AF01
  • Mechanism: Sodium channel stabiliser with enzyme‑inducing properties

Clinical Terms

CR/retard means controlled‑release or sustained release, written on some brands as CR, Retard or LP.

Therapeutic range refers to the estimated plasma concentration range where clinical benefit is expected with acceptable toxicity; monitoring is sometimes used when interactions or toxicity are suspected.

Enzyme inducer describes a drug that increases liver enzyme activity and speeds metabolism of itself or other medicines, which can reduce their effectiveness.

Indications & Off‑Label Uses

Approved Indications By TGA

Indication Typical Dosing TGA Approval Status
Partial Seizures Start 200 mg 1–2x/day; maintenance 800–1,200 mg/day TGA‑approved
Generalised Tonic–Clonic Seizures Individualised dosing within typical maintenance range TGA‑approved
Trigeminal Neuralgia Start 100–200 mg/day; maintenance 400–800 mg/day TGA‑approved

Off‑Label Uses In Australian Clinical Practice

Carbamazepine is sometimes used for bipolar disorder (acute mania and maintenance) when other mood stabilisers are unsuitable.

Off‑label prescribing should be accompanied by informed consent and closer monitoring for adverse effects.

  • Off‑Label Prescribing Checklist: document indication, rationale, informed consent, monitoring plan and review dates.

Key Clinical Findings

Systematic reviews and clinical experience support carbamazepine as effective for focal epilepsy and trigeminal neuralgia.

Benefits must be balanced against CNS side effects, haematologic and hepatic risks and a substantial interaction burden.

Australian practice emphasises baseline and periodic full blood count, liver function tests and serum sodium monitoring.

Recent literature through mid‑2024 highlights genetic screening for HLA‑B*1502 in at‑risk populations to reduce SJS/TEN risk and careful monitoring during titration.

  • Principal Takeaways: effective for focal epilepsy and neuropathic pain; narrow therapeutic index; enzyme inducer with multiple interactions; baseline bloods required.
Evidence Type Finding
Randomised Trials / RCTs Support efficacy in focal seizures and trigeminal neuralgia (see specialist guidelines)
Meta‑Analyses Confirm benefit vs placebo for neuralgia symptom control

Practical advice: refer to up‑to‑date clinical guidelines and specialist advice for complex cases.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Indications Major Side Effects Pregnancy Considerations PBS Status
Carbamazepine Partial seizures, trigeminal neuralgia CNS effects, hyponatraemia, blood dyscrasias Teratogenic risk; specialist review Many formulations PBS‑listed
Valproate Generalised seizures, bipolar Weight gain, liver toxicity, high teratogenic risk High congenital malformation risk; avoid in pregnancy if possible PBS‑listed; restrictions in pregnancy
Lamotrigine Focal and generalised seizures, bipolar maintenance Rash, may cause SJS rarely, fewer interactions Lower teratogenic signal than valproate but monitor PBS‑listed
Oxcarbazepine Focal seizures, alternative to carbamazepine Hyponatraemia, dizziness Less enzyme induction than carbamazepine; specialist review PBS‑listed in many cases
Phenytoin Focal seizures Gingival hyperplasia, ataxia, interactions Teratogenic risks; specialist review PBS‑listed

Pros And Cons Checklist

  • Consider seizure type suitability before switching.
  • Assess teratogenic risk — valproate carries higher pregnancy risk compared with carbamazepine.
  • Review interaction potential — carbamazepine is a strong inducer compared with lamotrigine or oxcarbazepine.
  • Weigh cognitive and tolerability profiles and the monitoring burden when counselling patients.

Common Questions

  • Effect On Contraception: carbamazepine may reduce hormonal contraceptive efficacy; discuss non‑hormonal backup or alternative methods with a prescriber.
  • Pregnancy Planning: discuss risks with a specialist obstetrician and neurologist and aim to use the lowest effective dose if continued.
  • Breastfeeding: consider individual risk–benefit and consult prescriber; monitor infant for sedation and feeding issues.
  • Switching Brands: controlled‑release versus immediate formulations are not interchangeable without prescriber advice; do not split CR tablets.
  • Storage: keep at 15–30°C in original packaging, away from moisture and sunlight.
  • Rash Or Suspected Allergic Reaction: stop the medicine immediately and seek urgent medical attention for any blistering or mucosal involvement.

Always contact the prescriber or local pharmacist for case‑specific guidance.

Price & Access Comparison

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range (28 Days) PBS Subsidy Status Prescription Required
Community Chain (Chemist Warehouse) Generic band: variable; branded higher Many formulations PBS‑listed; check at time of purchase Yes
Priceline Similar band to other chains; compare offers Check PBS Schedule Yes
TerryWhite Chemmart Typical retail pricing; PBS applies where eligible PBS available where criteria met Yes
Accredited Online Pharmacy May offer competitive pricing and home delivery PBS dispensing possible with valid script Yes

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm prescription type (PBS or private) before ordering.
  • Allow extra time for rural dispensing and delivery.
  • Ask about generic versus brand substitution and any cost difference.
  • Request pharmacist advice on monitoring plan and PBS paperwork if an Authority is required.

Registration & Regulation

TGA Approval

Carbamazepine products including Tegretol and Tegretol CR are TGA‑approved for indicated uses in Australia.

  • TGA — Therapeutic Goods Administration, regulator for medicines in Australia.
  • PBS — Pharmaceutical Benefits Scheme, provides subsidy details and Authority rules.
  • ARTG — Australian Register of Therapeutic Goods, listing for approved products.

PBS Subsidy Details

Many carbamazepine formulations are listed on the PBS but subsidy rules and Authority requirements depend on indication and patient category.

  • Dispensing Compliance Checklist: confirm PBS eligibility, complete Authority forms when required and retain PBS documentation.
  • Clinician Tip: verify current PBS Schedule entries for exact subsidy criteria before prescribing.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store carbamazepine at room temperature between 15–30°C in the original container and out of direct sunlight.

Do not leave tablets in cars, on dashboards or in bathrooms where heat and humidity can accelerate degradation.

Keep medicines out of reach of children and pets and secure when travelling.

  • Patient Storage Checklist: original pack, dry place, cool spot, child‑resistant container where available.
  • Travel Guidance: carry in hand luggage to avoid temperature extremes and keep a copy of the prescription when travelling interstate.

Cold‑Chain Handling For Pharmacies

No cold chain is required for standard oral carbamazepine products.

Pharmacies should store stock at controlled room temperature, monitor expiry dates and avoid dispensing split CR tablets.

  • SOP Checklist For Pharmacies: store 15–30°C, rotate stock, label CR formulations clearly and advise patients not to split CR tablets.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Confirm the indication and screen for prior allergy history and other medications before supply.

Explain the medicine purpose, expected onset and common early side effects such as drowsiness and nausea.

Advise patients to stop and seek urgent care for rashes, severe dizziness or signs of infection such as sore throat and unexplained bruising.

Discuss monitoring schedule including FBC, LFTs and serum sodium and document the plan.

Use teach‑back to confirm patient understanding of dosing and safety precautions.

  • Counselling Script Checklist: reason for treatment, dosing times, missed dose instructions, side effect red flags, contraception advice, driving/work safety, follow‑up blood tests.
  • Patient Handout Items: printed dosing schedule, blood test schedule and emergency contact details.

Patient Advice From PBS And National Health Authorities

Retain PBS documentation and attend scheduled blood tests as advised by the prescriber.

Report any rash, fever or unusual bleeding immediately.

Notify all health providers that you are taking carbamazepine to avoid prescribing conflicts and interactions.

  • Referral Prompts: refer to neurologist, psychiatrist or specialist pharmacist for complex polypharmacy or pregnancy planning.
  • Emergency Contacts: provide local GP, after‑hours clinic and emergency department contacts for urgent adverse reactions.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days

Final Notes

Tegretol (carbamazepine) is an established treatment for focal epilepsy and trigeminal neuralgia with demonstrated effectiveness when used and monitored appropriately.

Its safety profile requires baseline and periodic monitoring and attention to interactions that reduce effectiveness of other medicines.

When counselling patients, emphasise the need to report rashes, signs of infection, unusual bruising and any sedation that affects driving or work.

For specific dosing, pregnancy planning or complex interaction queries, refer to a treating specialist or pharmacist and consult current Australian guidance and the PBS Schedule for subsidy rules.

Related products